Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 361, pseudogene (RN7SL361P) is a non-coding RNA that belongs to the large family of 7SL RNA pseudogenes distributed throughout the human genome[1][3][5]. 7SL RNA is the RNA component of the signal recognition particle, but RN7SL361P is classified as a pseudogene, meaning it is a DNA segment similar to a functional gene but generally nonfunctional due to mutations or lack of regulatory elements[1][3][6][7]. The majority of 7SL RNA-derived sequences in the genome are pseudogenes, believed to arise from reverse transcription of 7SL RNA molecules followed by their genomic insertion[3][7]. Pseudogenes typically do not produce functional proteins; however, in some cases, pseudogene transcripts may contribute to gene regulation through RNA-mediated mechanisms (such as acting as endogenous competitive RNAs or antisense RNAs)[2][4]. These effects are described for some pseudogenes generally, but no specific functional or disease associations are established for RN7SL361P[1][2][3]. RN7SL361P is not considered a therapeutic target such as a receptor, enzyme, or transporter[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 361, pseudogene (RN7SL361P).